Dr. Eisen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Thomas Jefferson University
833 Chestnut Street
Philadelphia, PA 19107Phone+1 215-808-8082- Is this information wrong?
Summary
- Dr. Howard Eisen is a cardiologist in Philadelphia, PA and is affiliated with Thomas Jefferson University. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 36 years. He specializes in adult congenital heart disease and heart failure & transplantation and is experienced in coronary artery disease, cardiomyopathies, transplant cardiology, heart failure, and chronic heart failure. He has more than 100 publications and over 500 citings.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1987
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1981 - 1984
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1981 - 1982
- Perelman School of Medicine at the University of PennsylvaniaClass of 1981
- Cornell UniversityB.A., Biochemistry, Cum Laude, Phi Beta Kappa, 1973 - 1977
Certifications & Licensure
- NJ State Medical License 2018 - 2025
- MD State Medical License 2019 - 2024
- PA State Medical License 1982 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow American College of Physicians
- Fellow American Heart Association
- Fellow American Society of Transplantation
- Join now to see all
Clinical Trials
- Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity Start of enrollment: 2005 Nov 01
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Guiding Evidence Based Therapy Using Biomarker Intensified Treatment Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Autonomic Testing Optimizes Therapy for Heart Failure and Related Cardiovascular Disorders.Nicholas L DePace, Joe Colombo, Kaushik Mandal, Howard J Eisen> ;Current Cardiology Reports. 2022 Nov 1
- 3 citationsVitamin d deficiency and metabolic syndrome: The joint effect on cardiovascular and all-cause mortality in the United States adults.Longjian Liu, Saishi Cui, Stella L Volpe, Nathalie S May, Deeptha Sukumar, Rose Ann DiMaria-Ghalili, Howard J Eisen> ;World Journal of Cardiology. 2022 Jul 26
- How to preserve information equity for COVID-19 vaccination among severely immunocompromised populations: Challenges among heart transplant recipients in Japan.Tomoko S Kato, Harumi Gomi, Howard J Eisen, Sharon A Hunt> ;Clinical Transplantation. 2022 Sep 1
- Join now to see all
Journal Articles
- Novel, More Accurate Assessments of Renal Function in Heart Transplant Patients: Commentary on 'Chronic kidney disease after heart transplantation: a single-centre r...Kim DH, Eisen HJ, Transpl Int, 1/1/2016
- Pediatric Heart Transplant Recipients and Cardiac Allograft Vasculopathy: The Importance of HemodynamicsEisen HJ, J Am Coll Cardiol, 1/4/2015
- Improvements in Dutch heart transplant patient outcomes: lessons for the futureEisen HJ, Transpl Int, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Identification of cardiac allograft rejection using Raman spectrophotometryRassadi S, Chang C, Cao D, Eisen HJ, J Heart Lung Transplant, 1/1/2007
- Novel immunosuppressive strategies using a molecular diagnostic assay for weaning of immunosuppressive agentsAlbright K, Rowe T, Hankins SR, Eisen HJ, J Heart Lung Transplant, 1/1/2007
- Gene expression profiling distinguishes moderate to severe from mild acute cellular rejection in cardiac allograft recipientsBernstein D, Berry G, Billingham M, Marboe CC, Deng MC, Mital S, Eisen H, Williams GE, Baron H, Klingler TM, Wohlgemuth JG, Kobashigawa J, J Heart Lung Transplant, 1/1/2007
- Join now to see all
Lectures
- Debate:Cardiac Biopsies are Essential for Post-Transplant Surveillance (Con and rebuttal)Washington, DC - 1/27/2016
- Heart Failure Now and (Perhaps) in The FutureFeldkirch, Austria - 1/9/2016
- Biomarkers and Cardiac TransplantationSantander, Spain - 1/7/2016
- Join now to see all
Other
- Acute cardiac allograft rejection:treatmentJessup M, Eisen HJ, UpToDate in Medicine CD ROM
1/1/2014 - Cardiac transplant vasculopathy: pathophysiology, diagnosis and treatmentEisen HJ, UpToDate in Medicine CD ROM
1/1/2014 - Cardiac transplantation: post-transplant lymphoproliferative disordersEisen HJ, UpToDate in Medicine CD ROM
1/1/2014 - Join now to see all
Authored Content
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
Press Mentions
- Hospital Defends Decision to Deny Heart Transplant to Unvaccinated ManJanuary 27th, 2022
- Hospital Defends Decision to Deny Heart Transplant to Unvaccinated ManJanuary 27th, 2022
- Hospital Defends Itself After Unvaccinated Man Denied Heart TransplantJanuary 27th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: